Crossmark

Prognostic value of PSA kelim score in high-volume mCSPC patients treated with abiraterone or enzalutamide: a single-center retrospective study

Published Online: 2026-04-15

Authors

Oksuz, Sila

Kınıkoglu, Oguzcan

Sariyar, Nisanur

Ozdemir, Mert

Isik, Deniz

Surmeli, Heves

Ay, Seval

Odabas, Hatice

Turan, Nedim
License Information

Text and Data Mining valid from 2026-04-15

Accepted Manuscript valid from 2026-04-15
More Information

Article History

Received: 2 March 2026

Accepted: 13 April 2026

First Online: 15 April 2026

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current